Abiopharma

Brookdale Senior Living Inc. - Brookdale Announces 2026 Investor Day and Webcast

Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million

Brookdale Announces 2026 Investor Day and Webcast

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation

New Form EFFECT - MetaVia Inc. Filed: 2026-01-15 AccNo: 9999999995-26-000181 Size: 1 KB

New Form EFFECT - CRESCENT BIOPHARMA, INC. Filed: 2026-01-15 AccNo: 9999999995-26-000182 Size: 1 KB

New Form EFFECT - Canopy Growth Corp Filed: 2026-01-15 AccNo: 9999999995-26-000184 Size: 1 KB

Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027

BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027

New Form 3 - CorMedix Inc. Filed: 2026-01-15 AccNo: 0001213900-26-004855 Size: 11 KB

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.